Labstoclinic is an open access, peer reviewed journal dedicated to publishing high-quality research findings in cell signalling and diseases. Papers published by the journal represent advances in translational research and a novel therapeutic strategy to improve health quality. As we are committed to making prompt and informed decisions about publications,we encourage direct submission of your manuscript. However, we would like to hear pre-submission enquiries.
Our editorial decisions are made by a team of academic editors, who are doctorate-scientists. Information about the scientific background of the editors will be listed shortly. For general editorial enquiries, including manuscript submission queries, please contact the LC team. Contact details for other enquiries, including advertising and sponsorship opportunities will be available soon.
Confidentiality is our utmost priority and we aim to protect the privacy of all LC users and any confidential information regarding research publications and review article will be protected at the best level. Any information on user’s publication or reviewing material will not be available, before signing official digital agreement between the LC publication services and the users.
We invite contributions from established researchers in the field, as well as from budding and young researchers, who are at the beginning of their independent research career. We promise to give a serious consideration of your research works and valuable feedback from peers to improve the research quality and before successful publication.
We are organising team of scientific and technical experts to help authors to enhance impact of their research findings.
If you strongly believe your work research findings will add value to the scientific information, please start your submission today! We encourage authors to upload 2 files (a single text file and a single figure file). For any media file please upload video(s) on the link.
Title and Running Title (you may copy and paste this from your manuscript)
Abstract (you may copy and paste this from your manuscript)
Manuscript files in Word, Text, or PDF
Figures/Images in external files in TIFF, or JPG or PDF
Tables in Excel/word/Converted PDF
TIFF or JPEG, or embedded with the text of the Word/WordPerfect/RTF format manuscript
Contact information (e-mail address and institution) of desired peer reviewers (if any)
Ramesh Kumar (PhD), LC Journal.
Correspondence to firstname.lastname@example.org email@example.com
A commentary from Science news posted recently, Opposite effect: Protein widely known to fight tumours also boosts cancer growth. The Original article published by Kim et al’., in Cancer cell, indicating context dependent broader functions of p531.
evidences are required to strengthen the above-mentioned statement. More precisely, when we say opposite effect of p53 (Science news January 31, 2019).
Growing body evidences suggest that cancer cells with a wild type p53 does not essentially function as tumour suppressor. In fact, p53 copy number determines its roles2,3.
In normal circumstances, cancer cells having 2 copies of p53 act as tumour suppressor, however altered copy numbers have been implicated for tumorigenic functions in the context dependent manner. Here, I would like to point out the earlier exciting research findings on significance of the p53 copy numbers which give us a clue on why elephants are protected from Cancer4.
The guardian of the genome "TP53" is connected through a complex signalling networks and finding an optimal signalling tune is not an easy task. Interestingly, studies have also suggested that a mild increase in p53 copy number can boost our DNA damage responses, checkpoints, immune functions and triggers protection from cellular aging to cancinogenesis.
I would like to take opportunity of mentioning an earlier exciting research from García-Cao et. al., on Super p53" mice, carrying p53-tg alleles in addition to the two endogenous alleles. These mice exhibit enhanced DNA damage responses. Interestingly, in contrast to wild type mice, "super p53" mice were significantly protected from carcinogenesis. Moreover, in contrast to earlier reported mice with constitutively active p53, "super p53" mice was protected of premature aging5.
Overall, in cancer cells if p53 not mutated, the copy number dictates the tumor heterogeneity. In healthy cells, optimal copy number is beneficial for normal cellular functions. Conflict of interest- The author declares this article as a personal opinion presented through the LC journal, and has no conflict of interest with any governmental and nongovernmental organisation.